Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· December 16, 2025

Digital Wealth Partners Launches Algorithmic XRP Trading Strategy Powered by Arch Public for Qualified Retirement Accounts

View original at globenewswire.com
Digital Wealth Partners Launches Algorithmic XRP Trading Strategy Powered by Arch Public for Qualified Retirement Accounts Dallas, Texas , Dec…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Individual investors shouldn't be locked out of the same strategies institutions use

    80% confidence
  • Most XRP holders are either sitting on their position hoping it appreciates or actively trading on their own without a systematic framework

    80% confidence
  • The custody arrangement represents a meaningful advancement in how retail-accessible digital asset accounts can be structured

    80% confidence
  • Systematic digital asset trading with this level of custody protection and operational infrastructure has typically only been available through hedge funds and institutional trading desks until recently

    80% confidence
  • Digital Wealth Partners is not making a prediction about where XRP trades in five years, but stating the asset has the properties needed to execute the strategy effectively

    80% confidence
  • Digital Wealth Partners wanted to offer real insurance, real asset segregation, and cold storage security without requiring clients to become technical experts

    80% confidence
  • Most people storing XRP are either trusting an exchange or managing their own keys and hoping nothing goes wrong

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com